Airborne settlement nothing to sneeze at

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.


The company behind cold remedy Airborne has just been officially slapped on the wrist by the Federal Trade Commission. Mentioned in Mental Floss’s list of shameless false-advertising schemes, the ads and packaging dubiously claimed that Airborne could somehow prevent you from catching a cold. Now, the FTC is ordering the company to pay consumers back for as many as six purchases each, at an estimated total cost of $30 million. If you bought Airborne between 2001 and 2008, you have until Sept.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in